Basic Information
LncRNA/CircRNA Name | CCHE1 |
Synonyms | NA |
Region | GRCh38_1:29554-31109 |
Ensemble | |
Refseq | NR_131782 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | colorectal cancer |
ICD-0-3 | C19.9 |
Methods | qPCR, in vitro knockdown, etc. |
Sample | Colonic tissue |
Expression Pattern | up-regulated |
Function Description | lncRNA-CCHE1 expression was upregulated in CRC tissues compared to adjacent non-cancerous tissues, and was significantly associated with larger tumor size, less differentiated histology, advanced dukes stage, positive lymph node involvement and vascular invasion. It also showed a significant positive correlation with the expression of p-ERK1/2, COX-2 as well as cyclin D1and PCNA (as markers for cell proliferation). These findings signify that lncRNA-CCHE1 is a key oncogene possibly involved in CRC development and progression by modulating ERK/COX-2 pathway and cell proliferation activity. |
Pubmed ID | 30484108 |
Year | 2018 |
Title | Expression of long non-coding RNA CCHE1 in colorectal carcinoma: correlations with clinicopathological features and ERK/COX-2 pathway |
External Links
Links for CCHE1 | GenBank HGNC NONCODE |
Links for colorectal cancer | OMIM COSMIC |